SECTIONS
ET APPS
ENGLISH
E-PAPER
FOLLOW US
Pharmaceuticals
Home Biotech
Industry Healthcare
Auto
Banking/Finance
LATEST NEWS BJP's 'yummy mummy problem', according to Asaduddin Owaisi
Cons. Products
Energy
Ind'l Goods/Svs
Healthcare/Biotech Services
EOD
M ARKET STATS
More
Pharmaceuticals
ET Home › Industry › Healthcare/Biotech › Pharmaceuticals
04:05 PM | 31 MAR
SIGN-IN
SENSEX
29,620
Search for New s, Stock Quotes & NAV's
NIFTY 50
-26.92
9,173
0.00
GOLD (MCX) (Rs/10g.)
USD/INR
28,451.00
64.85
-91.00
-0.07
CREATE PORTFOLIO
Download ET MARKETS APP
CHOOSE LANGUAGE
ENG
Pharma companies optimistic on IndoUS deal corridor: Report By PTI | Updated: Mar 31, 2017, 07.48 PM IST
Post a Com m ent
READ MORE ON » Speed | Regulations | Product | Portfolio | Mumbai | Investments
MUMBAI: Despite the increasing protectionist tendencies in the US, domestic pharma sector, which saw 51 deals worth $4.6 billion in 2016, is cautiously optimistic about the inbound deals from the American shores this year, says a report.
Like
Share 4M people like this. Sign Up to see w hat your friends like.
According to an EY report, outbound and domestic transactions drove most of the deal activity in 2016, with 21 deals each. In terms of disclosed deal value, the deal size stood at $2.1 billion each. Domestic deal making was dominated by smaller value bands with an deal value of $342
Save web pages as PDF manually or automatically w ith PDFmyURL